BONE 润色咨询

BONE

出版年份：1985 年文章数：6248 投稿命中率： 开通期刊会员，数据随心看

出版周期：Monthly 自引率：6.3% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=580463, encodeId=8cb6580463aa, content=这个杂志有版面费吗？<span class="quote">132****5832暂无昵称 2019-10-25 00:00:00 发表:<br>3个月</span>, beContent=132****5832暂无昵称 2019-10-25 00:00:00 发表: 3个月, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eo1Cbu9ibBiberkfx5dlu9cx1y63eGbtEEoTqskIOcnZ6lbYHErSGPR7r2R4hGmcqfjMlF7Bqo6ibxFQ/132, createdBy=34e51644539, createdName=diyizhaozhao, createdTime=Tue Nov 26 00:00:00 CST 2019, time=2019-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578691, encodeId=ffbf5e869116, content=3个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=213, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571993, encodeId=f5225e1993b8, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：有点坑，一审一个多月回来只说语言问题，润色回去后二审回来让转投bone reports, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/07/992397a31de8fe085a03a096beddda25.jpg, createdBy=9a581635059, createdName=Moke8966, createdTime=Sat Jun 08 00:00:00 CST 2019, time=2019-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849024, encodeId=d40784902403, content=内分泌学非常好的一个期刊，可以试着投一下，拒了也能收获不少意见 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dedd5414056, createdName=ms5251117139357251, createdTime=Wed Jan 02 14:27:24 CST 2019, time=2019-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551660, encodeId=7d7c551660d8, content=有没有大神算一下目前IF是多少？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=380, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLds0cj9RtZuibJXicmzqkfrVLvicKfIGVIpECSvhWlEwVdW8dUP8iaNFomtZrbQmbD1Nib2SOE1ck6GGg/132, createdBy=b03c1669891, createdName=zxyspine, createdTime=Fri Jan 19 08:48:00 CST 2018, time=2018-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548793, encodeId=af67548e93e3, content=是否接受中药提取物，中药单体这种？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=297, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/11/099c0105710974ef7b8f24c4ed199641.jpg, createdBy=f30e2045285, createdName=sesee, createdTime=Wed Nov 01 00:30:00 CST 2017, time=2017-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547595, encodeId=1e6b54e59586, content=你好.看样子蛮顺利的.<span class="quote">liudm0103 2016-06-16 发表::<br>研究方向:骨质疏松;基础研究; 审稿时间:约2个月 SCI(2014):3.973 2016-02-21 Submitted to journal 2016-02-22 With editor 2016-03-13 under review 2016-04-10 revise 2016-05-25 Revision Submitted to Journal 2016-05-26 With editor 2016-05-29 Completely accepted</span><span class="quote">liudm0103 2016-06-16 22:14:00 发表:<br>2016-02-21 Submitted to journal <br> 2016-02-22 With editor <br> 2016-03-13 under review <br> 2016-04-10 revise <br> 2016-05-25 Revision Submitted to Journal <br> 2016-05-26 With editor <br> 2016-05-29 Completely accepted</span>, beContent=liudm0103 2016-06-16 发表:: 研究方向:骨质疏松;基础研究; 审稿时间:约2个月 SCI(2014):3.973 2016-02-21 Submitted to journal 2016-02-22 With editor 2016-03-13 under review 2016-04-10 revise 2016-05-25 Revision Submitted to Journal 2016-05-26 With editor 2016-05-29 Completely accepted, objectType=tool_impact_factor, channel=null, level=null, likeNumber=377, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84812146588, createdName=txsyzu_32760595, createdTime=Mon Sep 25 00:00:00 CST 2017, time=2017-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=523818, encodeId=2c82523818ff, content=审稿速度:2.0<br>经验分享：2016-02-21 Submitted to journal <br> 2016-02-22 With editor <br> 2016-03-13 under review <br> 2016-04-10 revise <br> 2016-05-25 Revision Submitted to Journal <br> 2016-05-26 With editor <br> 2016-05-29 Completely accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=467, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=922218466, createdName=liudm0103, createdTime=Thu Jun 16 22:14:00 CST 2016, time=2016-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=511320, encodeId=2127511320f6, content=后续报道： <br> Bone是二区的杂志，审稿很严。。 <br> 去年11月底投出，审了两个多快三个月，2月份major revision and reconsider，三个reviewer的意见有30条左右。。仔细修改，反复讨论，改了满江红，三月初再投。 <br> 二审又审了一个月左右，两个reviewer接收，另一个reviewer同意接收但是对讨论和前言部分做了几处修改建议，所以然后小修，然后过了两三天，正式接收。 <br> 感觉：bone很严谨，每一处小细节都能问。不过针对意见好好回答，接收机会还是很大的。 <br> 各位同仁加油！ <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=571, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5cfa1614315, createdName=mileo, createdTime=Mon Apr 20 23:35:00 CST 2015, time=2015-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509631, encodeId=d1e750963180, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：Bone作为骨科领域老大（基础领域），而且审稿很古板，一直是超严格的。因此，发表真不容易，但若发表了，价值当然不低。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=506, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Sat Feb 07 10:34:00 CST 2015, time=2015-02-07, status=1, ipAttribution=)]
    2019-11-26 diyizhaozhao

    这个杂志有版面费吗？132****5832暂无昵称 2019-10-25 00:00:00 发表:
    3个月

    132****5832暂无昵称 2019-10-25 00:00:00 发表: 3个月

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=580463, encodeId=8cb6580463aa, content=这个杂志有版面费吗？<span class="quote">132****5832暂无昵称 2019-10-25 00:00:00 发表:<br>3个月</span>, beContent=132****5832暂无昵称 2019-10-25 00:00:00 发表: 3个月, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eo1Cbu9ibBiberkfx5dlu9cx1y63eGbtEEoTqskIOcnZ6lbYHErSGPR7r2R4hGmcqfjMlF7Bqo6ibxFQ/132, createdBy=34e51644539, createdName=diyizhaozhao, createdTime=Tue Nov 26 00:00:00 CST 2019, time=2019-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578691, encodeId=ffbf5e869116, content=3个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=213, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571993, encodeId=f5225e1993b8, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：有点坑，一审一个多月回来只说语言问题，润色回去后二审回来让转投bone reports, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/07/992397a31de8fe085a03a096beddda25.jpg, createdBy=9a581635059, createdName=Moke8966, createdTime=Sat Jun 08 00:00:00 CST 2019, time=2019-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849024, encodeId=d40784902403, content=内分泌学非常好的一个期刊，可以试着投一下，拒了也能收获不少意见 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dedd5414056, createdName=ms5251117139357251, createdTime=Wed Jan 02 14:27:24 CST 2019, time=2019-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551660, encodeId=7d7c551660d8, content=有没有大神算一下目前IF是多少？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=380, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLds0cj9RtZuibJXicmzqkfrVLvicKfIGVIpECSvhWlEwVdW8dUP8iaNFomtZrbQmbD1Nib2SOE1ck6GGg/132, createdBy=b03c1669891, createdName=zxyspine, createdTime=Fri Jan 19 08:48:00 CST 2018, time=2018-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548793, encodeId=af67548e93e3, content=是否接受中药提取物，中药单体这种？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=297, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/11/099c0105710974ef7b8f24c4ed199641.jpg, createdBy=f30e2045285, createdName=sesee, createdTime=Wed Nov 01 00:30:00 CST 2017, time=2017-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547595, encodeId=1e6b54e59586, content=你好.看样子蛮顺利的.<span class="quote">liudm0103 2016-06-16 发表::<br>研究方向:骨质疏松;基础研究; 审稿时间:约2个月 SCI(2014):3.973 2016-02-21 Submitted to journal 2016-02-22 With editor 2016-03-13 under review 2016-04-10 revise 2016-05-25 Revision Submitted to Journal 2016-05-26 With editor 2016-05-29 Completely accepted</span><span class="quote">liudm0103 2016-06-16 22:14:00 发表:<br>2016-02-21 Submitted to journal <br> 2016-02-22 With editor <br> 2016-03-13 under review <br> 2016-04-10 revise <br> 2016-05-25 Revision Submitted to Journal <br> 2016-05-26 With editor <br> 2016-05-29 Completely accepted</span>, beContent=liudm0103 2016-06-16 发表:: 研究方向:骨质疏松;基础研究; 审稿时间:约2个月 SCI(2014):3.973 2016-02-21 Submitted to journal 2016-02-22 With editor 2016-03-13 under review 2016-04-10 revise 2016-05-25 Revision Submitted to Journal 2016-05-26 With editor 2016-05-29 Completely accepted, objectType=tool_impact_factor, channel=null, level=null, likeNumber=377, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84812146588, createdName=txsyzu_32760595, createdTime=Mon Sep 25 00:00:00 CST 2017, time=2017-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=523818, encodeId=2c82523818ff, content=审稿速度:2.0<br>经验分享：2016-02-21 Submitted to journal <br> 2016-02-22 With editor <br> 2016-03-13 under review <br> 2016-04-10 revise <br> 2016-05-25 Revision Submitted to Journal <br> 2016-05-26 With editor <br> 2016-05-29 Completely accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=467, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=922218466, createdName=liudm0103, createdTime=Thu Jun 16 22:14:00 CST 2016, time=2016-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=511320, encodeId=2127511320f6, content=后续报道： <br> Bone是二区的杂志，审稿很严。。 <br> 去年11月底投出，审了两个多快三个月，2月份major revision and reconsider，三个reviewer的意见有30条左右。。仔细修改，反复讨论，改了满江红，三月初再投。 <br> 二审又审了一个月左右，两个reviewer接收，另一个reviewer同意接收但是对讨论和前言部分做了几处修改建议，所以然后小修，然后过了两三天，正式接收。 <br> 感觉：bone很严谨，每一处小细节都能问。不过针对意见好好回答，接收机会还是很大的。 <br> 各位同仁加油！ <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=571, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5cfa1614315, createdName=mileo, createdTime=Mon Apr 20 23:35:00 CST 2015, time=2015-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509631, encodeId=d1e750963180, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：Bone作为骨科领域老大（基础领域），而且审稿很古板，一直是超严格的。因此，发表真不容易，但若发表了，价值当然不低。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=506, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Sat Feb 07 10:34:00 CST 2015, time=2015-02-07, status=1, ipAttribution=)]
    2019-10-25 147612bem32暂无昵称

    3个月

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=580463, encodeId=8cb6580463aa, content=这个杂志有版面费吗？<span class="quote">132****5832暂无昵称 2019-10-25 00:00:00 发表:<br>3个月</span>, beContent=132****5832暂无昵称 2019-10-25 00:00:00 发表: 3个月, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eo1Cbu9ibBiberkfx5dlu9cx1y63eGbtEEoTqskIOcnZ6lbYHErSGPR7r2R4hGmcqfjMlF7Bqo6ibxFQ/132, createdBy=34e51644539, createdName=diyizhaozhao, createdTime=Tue Nov 26 00:00:00 CST 2019, time=2019-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578691, encodeId=ffbf5e869116, content=3个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=213, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571993, encodeId=f5225e1993b8, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：有点坑，一审一个多月回来只说语言问题，润色回去后二审回来让转投bone reports, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/07/992397a31de8fe085a03a096beddda25.jpg, createdBy=9a581635059, createdName=Moke8966, createdTime=Sat Jun 08 00:00:00 CST 2019, time=2019-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849024, encodeId=d40784902403, content=内分泌学非常好的一个期刊，可以试着投一下，拒了也能收获不少意见 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dedd5414056, createdName=ms5251117139357251, createdTime=Wed Jan 02 14:27:24 CST 2019, time=2019-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551660, encodeId=7d7c551660d8, content=有没有大神算一下目前IF是多少？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=380, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLds0cj9RtZuibJXicmzqkfrVLvicKfIGVIpECSvhWlEwVdW8dUP8iaNFomtZrbQmbD1Nib2SOE1ck6GGg/132, createdBy=b03c1669891, createdName=zxyspine, createdTime=Fri Jan 19 08:48:00 CST 2018, time=2018-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548793, encodeId=af67548e93e3, content=是否接受中药提取物，中药单体这种？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=297, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/11/099c0105710974ef7b8f24c4ed199641.jpg, createdBy=f30e2045285, createdName=sesee, createdTime=Wed Nov 01 00:30:00 CST 2017, time=2017-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547595, encodeId=1e6b54e59586, content=你好.看样子蛮顺利的.<span class="quote">liudm0103 2016-06-16 发表::<br>研究方向:骨质疏松;基础研究; 审稿时间:约2个月 SCI(2014):3.973 2016-02-21 Submitted to journal 2016-02-22 With editor 2016-03-13 under review 2016-04-10 revise 2016-05-25 Revision Submitted to Journal 2016-05-26 With editor 2016-05-29 Completely accepted</span><span class="quote">liudm0103 2016-06-16 22:14:00 发表:<br>2016-02-21 Submitted to journal <br> 2016-02-22 With editor <br> 2016-03-13 under review <br> 2016-04-10 revise <br> 2016-05-25 Revision Submitted to Journal <br> 2016-05-26 With editor <br> 2016-05-29 Completely accepted</span>, beContent=liudm0103 2016-06-16 发表:: 研究方向:骨质疏松;基础研究; 审稿时间:约2个月 SCI(2014):3.973 2016-02-21 Submitted to journal 2016-02-22 With editor 2016-03-13 under review 2016-04-10 revise 2016-05-25 Revision Submitted to Journal 2016-05-26 With editor 2016-05-29 Completely accepted, objectType=tool_impact_factor, channel=null, level=null, likeNumber=377, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84812146588, createdName=txsyzu_32760595, createdTime=Mon Sep 25 00:00:00 CST 2017, time=2017-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=523818, encodeId=2c82523818ff, content=审稿速度:2.0<br>经验分享：2016-02-21 Submitted to journal <br> 2016-02-22 With editor <br> 2016-03-13 under review <br> 2016-04-10 revise <br> 2016-05-25 Revision Submitted to Journal <br> 2016-05-26 With editor <br> 2016-05-29 Completely accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=467, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=922218466, createdName=liudm0103, createdTime=Thu Jun 16 22:14:00 CST 2016, time=2016-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=511320, encodeId=2127511320f6, content=后续报道： <br> Bone是二区的杂志，审稿很严。。 <br> 去年11月底投出，审了两个多快三个月，2月份major revision and reconsider，三个reviewer的意见有30条左右。。仔细修改，反复讨论，改了满江红，三月初再投。 <br> 二审又审了一个月左右，两个reviewer接收，另一个reviewer同意接收但是对讨论和前言部分做了几处修改建议，所以然后小修，然后过了两三天，正式接收。 <br> 感觉：bone很严谨，每一处小细节都能问。不过针对意见好好回答，接收机会还是很大的。 <br> 各位同仁加油！ <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=571, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5cfa1614315, createdName=mileo, createdTime=Mon Apr 20 23:35:00 CST 2015, time=2015-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509631, encodeId=d1e750963180, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：Bone作为骨科领域老大（基础领域），而且审稿很古板，一直是超严格的。因此，发表真不容易，但若发表了，价值当然不低。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=506, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Sat Feb 07 10:34:00 CST 2015, time=2015-02-07, status=1, ipAttribution=)]
    2019-06-08 Moke8966

    审稿速度:2.0 | 投稿命中率:25.0
    经验分享：有点坑，一审一个多月回来只说语言问题，润色回去后二审回来让转投bone reports

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=580463, encodeId=8cb6580463aa, content=这个杂志有版面费吗？<span class="quote">132****5832暂无昵称 2019-10-25 00:00:00 发表:<br>3个月</span>, beContent=132****5832暂无昵称 2019-10-25 00:00:00 发表: 3个月, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eo1Cbu9ibBiberkfx5dlu9cx1y63eGbtEEoTqskIOcnZ6lbYHErSGPR7r2R4hGmcqfjMlF7Bqo6ibxFQ/132, createdBy=34e51644539, createdName=diyizhaozhao, createdTime=Tue Nov 26 00:00:00 CST 2019, time=2019-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578691, encodeId=ffbf5e869116, content=3个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=213, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571993, encodeId=f5225e1993b8, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：有点坑，一审一个多月回来只说语言问题，润色回去后二审回来让转投bone reports, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/07/992397a31de8fe085a03a096beddda25.jpg, createdBy=9a581635059, createdName=Moke8966, createdTime=Sat Jun 08 00:00:00 CST 2019, time=2019-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849024, encodeId=d40784902403, content=内分泌学非常好的一个期刊，可以试着投一下，拒了也能收获不少意见 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dedd5414056, createdName=ms5251117139357251, createdTime=Wed Jan 02 14:27:24 CST 2019, time=2019-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551660, encodeId=7d7c551660d8, content=有没有大神算一下目前IF是多少？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=380, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLds0cj9RtZuibJXicmzqkfrVLvicKfIGVIpECSvhWlEwVdW8dUP8iaNFomtZrbQmbD1Nib2SOE1ck6GGg/132, createdBy=b03c1669891, createdName=zxyspine, createdTime=Fri Jan 19 08:48:00 CST 2018, time=2018-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548793, encodeId=af67548e93e3, content=是否接受中药提取物，中药单体这种？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=297, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/11/099c0105710974ef7b8f24c4ed199641.jpg, createdBy=f30e2045285, createdName=sesee, createdTime=Wed Nov 01 00:30:00 CST 2017, time=2017-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547595, encodeId=1e6b54e59586, content=你好.看样子蛮顺利的.<span class="quote">liudm0103 2016-06-16 发表::<br>研究方向:骨质疏松;基础研究; 审稿时间:约2个月 SCI(2014):3.973 2016-02-21 Submitted to journal 2016-02-22 With editor 2016-03-13 under review 2016-04-10 revise 2016-05-25 Revision Submitted to Journal 2016-05-26 With editor 2016-05-29 Completely accepted</span><span class="quote">liudm0103 2016-06-16 22:14:00 发表:<br>2016-02-21 Submitted to journal <br> 2016-02-22 With editor <br> 2016-03-13 under review <br> 2016-04-10 revise <br> 2016-05-25 Revision Submitted to Journal <br> 2016-05-26 With editor <br> 2016-05-29 Completely accepted</span>, beContent=liudm0103 2016-06-16 发表:: 研究方向:骨质疏松;基础研究; 审稿时间:约2个月 SCI(2014):3.973 2016-02-21 Submitted to journal 2016-02-22 With editor 2016-03-13 under review 2016-04-10 revise 2016-05-25 Revision Submitted to Journal 2016-05-26 With editor 2016-05-29 Completely accepted, objectType=tool_impact_factor, channel=null, level=null, likeNumber=377, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84812146588, createdName=txsyzu_32760595, createdTime=Mon Sep 25 00:00:00 CST 2017, time=2017-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=523818, encodeId=2c82523818ff, content=审稿速度:2.0<br>经验分享：2016-02-21 Submitted to journal <br> 2016-02-22 With editor <br> 2016-03-13 under review <br> 2016-04-10 revise <br> 2016-05-25 Revision Submitted to Journal <br> 2016-05-26 With editor <br> 2016-05-29 Completely accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=467, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=922218466, createdName=liudm0103, createdTime=Thu Jun 16 22:14:00 CST 2016, time=2016-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=511320, encodeId=2127511320f6, content=后续报道： <br> Bone是二区的杂志，审稿很严。。 <br> 去年11月底投出，审了两个多快三个月，2月份major revision and reconsider，三个reviewer的意见有30条左右。。仔细修改，反复讨论，改了满江红，三月初再投。 <br> 二审又审了一个月左右，两个reviewer接收，另一个reviewer同意接收但是对讨论和前言部分做了几处修改建议，所以然后小修，然后过了两三天，正式接收。 <br> 感觉：bone很严谨，每一处小细节都能问。不过针对意见好好回答，接收机会还是很大的。 <br> 各位同仁加油！ <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=571, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5cfa1614315, createdName=mileo, createdTime=Mon Apr 20 23:35:00 CST 2015, time=2015-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509631, encodeId=d1e750963180, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：Bone作为骨科领域老大（基础领域），而且审稿很古板，一直是超严格的。因此，发表真不容易，但若发表了，价值当然不低。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=506, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Sat Feb 07 10:34:00 CST 2015, time=2015-02-07, status=1, ipAttribution=)]
    2019-01-02 ms5251117139357251

    内分泌学非常好的一个期刊，可以试着投一下，拒了也能收获不少意见

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=580463, encodeId=8cb6580463aa, content=这个杂志有版面费吗？<span class="quote">132****5832暂无昵称 2019-10-25 00:00:00 发表:<br>3个月</span>, beContent=132****5832暂无昵称 2019-10-25 00:00:00 发表: 3个月, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eo1Cbu9ibBiberkfx5dlu9cx1y63eGbtEEoTqskIOcnZ6lbYHErSGPR7r2R4hGmcqfjMlF7Bqo6ibxFQ/132, createdBy=34e51644539, createdName=diyizhaozhao, createdTime=Tue Nov 26 00:00:00 CST 2019, time=2019-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578691, encodeId=ffbf5e869116, content=3个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=213, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571993, encodeId=f5225e1993b8, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：有点坑，一审一个多月回来只说语言问题，润色回去后二审回来让转投bone reports, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/07/992397a31de8fe085a03a096beddda25.jpg, createdBy=9a581635059, createdName=Moke8966, createdTime=Sat Jun 08 00:00:00 CST 2019, time=2019-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849024, encodeId=d40784902403, content=内分泌学非常好的一个期刊，可以试着投一下，拒了也能收获不少意见 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dedd5414056, createdName=ms5251117139357251, createdTime=Wed Jan 02 14:27:24 CST 2019, time=2019-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551660, encodeId=7d7c551660d8, content=有没有大神算一下目前IF是多少？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=380, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLds0cj9RtZuibJXicmzqkfrVLvicKfIGVIpECSvhWlEwVdW8dUP8iaNFomtZrbQmbD1Nib2SOE1ck6GGg/132, createdBy=b03c1669891, createdName=zxyspine, createdTime=Fri Jan 19 08:48:00 CST 2018, time=2018-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548793, encodeId=af67548e93e3, content=是否接受中药提取物，中药单体这种？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=297, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/11/099c0105710974ef7b8f24c4ed199641.jpg, createdBy=f30e2045285, createdName=sesee, createdTime=Wed Nov 01 00:30:00 CST 2017, time=2017-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547595, encodeId=1e6b54e59586, content=你好.看样子蛮顺利的.<span class="quote">liudm0103 2016-06-16 发表::<br>研究方向:骨质疏松;基础研究; 审稿时间:约2个月 SCI(2014):3.973 2016-02-21 Submitted to journal 2016-02-22 With editor 2016-03-13 under review 2016-04-10 revise 2016-05-25 Revision Submitted to Journal 2016-05-26 With editor 2016-05-29 Completely accepted</span><span class="quote">liudm0103 2016-06-16 22:14:00 发表:<br>2016-02-21 Submitted to journal <br> 2016-02-22 With editor <br> 2016-03-13 under review <br> 2016-04-10 revise <br> 2016-05-25 Revision Submitted to Journal <br> 2016-05-26 With editor <br> 2016-05-29 Completely accepted</span>, beContent=liudm0103 2016-06-16 发表:: 研究方向:骨质疏松;基础研究; 审稿时间:约2个月 SCI(2014):3.973 2016-02-21 Submitted to journal 2016-02-22 With editor 2016-03-13 under review 2016-04-10 revise 2016-05-25 Revision Submitted to Journal 2016-05-26 With editor 2016-05-29 Completely accepted, objectType=tool_impact_factor, channel=null, level=null, likeNumber=377, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84812146588, createdName=txsyzu_32760595, createdTime=Mon Sep 25 00:00:00 CST 2017, time=2017-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=523818, encodeId=2c82523818ff, content=审稿速度:2.0<br>经验分享：2016-02-21 Submitted to journal <br> 2016-02-22 With editor <br> 2016-03-13 under review <br> 2016-04-10 revise <br> 2016-05-25 Revision Submitted to Journal <br> 2016-05-26 With editor <br> 2016-05-29 Completely accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=467, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=922218466, createdName=liudm0103, createdTime=Thu Jun 16 22:14:00 CST 2016, time=2016-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=511320, encodeId=2127511320f6, content=后续报道： <br> Bone是二区的杂志，审稿很严。。 <br> 去年11月底投出，审了两个多快三个月，2月份major revision and reconsider，三个reviewer的意见有30条左右。。仔细修改，反复讨论，改了满江红，三月初再投。 <br> 二审又审了一个月左右，两个reviewer接收，另一个reviewer同意接收但是对讨论和前言部分做了几处修改建议，所以然后小修，然后过了两三天，正式接收。 <br> 感觉：bone很严谨，每一处小细节都能问。不过针对意见好好回答，接收机会还是很大的。 <br> 各位同仁加油！ <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=571, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5cfa1614315, createdName=mileo, createdTime=Mon Apr 20 23:35:00 CST 2015, time=2015-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509631, encodeId=d1e750963180, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：Bone作为骨科领域老大（基础领域），而且审稿很古板，一直是超严格的。因此，发表真不容易，但若发表了，价值当然不低。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=506, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Sat Feb 07 10:34:00 CST 2015, time=2015-02-07, status=1, ipAttribution=)]
    2018-01-19 zxyspine

    有没有大神算一下目前IF是多少？

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=580463, encodeId=8cb6580463aa, content=这个杂志有版面费吗？<span class="quote">132****5832暂无昵称 2019-10-25 00:00:00 发表:<br>3个月</span>, beContent=132****5832暂无昵称 2019-10-25 00:00:00 发表: 3个月, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eo1Cbu9ibBiberkfx5dlu9cx1y63eGbtEEoTqskIOcnZ6lbYHErSGPR7r2R4hGmcqfjMlF7Bqo6ibxFQ/132, createdBy=34e51644539, createdName=diyizhaozhao, createdTime=Tue Nov 26 00:00:00 CST 2019, time=2019-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578691, encodeId=ffbf5e869116, content=3个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=213, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571993, encodeId=f5225e1993b8, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：有点坑，一审一个多月回来只说语言问题，润色回去后二审回来让转投bone reports, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/07/992397a31de8fe085a03a096beddda25.jpg, createdBy=9a581635059, createdName=Moke8966, createdTime=Sat Jun 08 00:00:00 CST 2019, time=2019-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849024, encodeId=d40784902403, content=内分泌学非常好的一个期刊，可以试着投一下，拒了也能收获不少意见 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dedd5414056, createdName=ms5251117139357251, createdTime=Wed Jan 02 14:27:24 CST 2019, time=2019-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551660, encodeId=7d7c551660d8, content=有没有大神算一下目前IF是多少？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=380, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLds0cj9RtZuibJXicmzqkfrVLvicKfIGVIpECSvhWlEwVdW8dUP8iaNFomtZrbQmbD1Nib2SOE1ck6GGg/132, createdBy=b03c1669891, createdName=zxyspine, createdTime=Fri Jan 19 08:48:00 CST 2018, time=2018-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548793, encodeId=af67548e93e3, content=是否接受中药提取物，中药单体这种？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=297, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/11/099c0105710974ef7b8f24c4ed199641.jpg, createdBy=f30e2045285, createdName=sesee, createdTime=Wed Nov 01 00:30:00 CST 2017, time=2017-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547595, encodeId=1e6b54e59586, content=你好.看样子蛮顺利的.<span class="quote">liudm0103 2016-06-16 发表::<br>研究方向:骨质疏松;基础研究; 审稿时间:约2个月 SCI(2014):3.973 2016-02-21 Submitted to journal 2016-02-22 With editor 2016-03-13 under review 2016-04-10 revise 2016-05-25 Revision Submitted to Journal 2016-05-26 With editor 2016-05-29 Completely accepted</span><span class="quote">liudm0103 2016-06-16 22:14:00 发表:<br>2016-02-21 Submitted to journal <br> 2016-02-22 With editor <br> 2016-03-13 under review <br> 2016-04-10 revise <br> 2016-05-25 Revision Submitted to Journal <br> 2016-05-26 With editor <br> 2016-05-29 Completely accepted</span>, beContent=liudm0103 2016-06-16 发表:: 研究方向:骨质疏松;基础研究; 审稿时间:约2个月 SCI(2014):3.973 2016-02-21 Submitted to journal 2016-02-22 With editor 2016-03-13 under review 2016-04-10 revise 2016-05-25 Revision Submitted to Journal 2016-05-26 With editor 2016-05-29 Completely accepted, objectType=tool_impact_factor, channel=null, level=null, likeNumber=377, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84812146588, createdName=txsyzu_32760595, createdTime=Mon Sep 25 00:00:00 CST 2017, time=2017-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=523818, encodeId=2c82523818ff, content=审稿速度:2.0<br>经验分享：2016-02-21 Submitted to journal <br> 2016-02-22 With editor <br> 2016-03-13 under review <br> 2016-04-10 revise <br> 2016-05-25 Revision Submitted to Journal <br> 2016-05-26 With editor <br> 2016-05-29 Completely accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=467, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=922218466, createdName=liudm0103, createdTime=Thu Jun 16 22:14:00 CST 2016, time=2016-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=511320, encodeId=2127511320f6, content=后续报道： <br> Bone是二区的杂志，审稿很严。。 <br> 去年11月底投出，审了两个多快三个月，2月份major revision and reconsider，三个reviewer的意见有30条左右。。仔细修改，反复讨论，改了满江红，三月初再投。 <br> 二审又审了一个月左右，两个reviewer接收，另一个reviewer同意接收但是对讨论和前言部分做了几处修改建议，所以然后小修，然后过了两三天，正式接收。 <br> 感觉：bone很严谨，每一处小细节都能问。不过针对意见好好回答，接收机会还是很大的。 <br> 各位同仁加油！ <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=571, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5cfa1614315, createdName=mileo, createdTime=Mon Apr 20 23:35:00 CST 2015, time=2015-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509631, encodeId=d1e750963180, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：Bone作为骨科领域老大（基础领域），而且审稿很古板，一直是超严格的。因此，发表真不容易，但若发表了，价值当然不低。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=506, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Sat Feb 07 10:34:00 CST 2015, time=2015-02-07, status=1, ipAttribution=)]
    2017-11-01 sesee

    是否接受中药提取物，中药单体这种？？

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=580463, encodeId=8cb6580463aa, content=这个杂志有版面费吗？<span class="quote">132****5832暂无昵称 2019-10-25 00:00:00 发表:<br>3个月</span>, beContent=132****5832暂无昵称 2019-10-25 00:00:00 发表: 3个月, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eo1Cbu9ibBiberkfx5dlu9cx1y63eGbtEEoTqskIOcnZ6lbYHErSGPR7r2R4hGmcqfjMlF7Bqo6ibxFQ/132, createdBy=34e51644539, createdName=diyizhaozhao, createdTime=Tue Nov 26 00:00:00 CST 2019, time=2019-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578691, encodeId=ffbf5e869116, content=3个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=213, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571993, encodeId=f5225e1993b8, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：有点坑，一审一个多月回来只说语言问题，润色回去后二审回来让转投bone reports, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/07/992397a31de8fe085a03a096beddda25.jpg, createdBy=9a581635059, createdName=Moke8966, createdTime=Sat Jun 08 00:00:00 CST 2019, time=2019-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849024, encodeId=d40784902403, content=内分泌学非常好的一个期刊，可以试着投一下，拒了也能收获不少意见 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dedd5414056, createdName=ms5251117139357251, createdTime=Wed Jan 02 14:27:24 CST 2019, time=2019-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551660, encodeId=7d7c551660d8, content=有没有大神算一下目前IF是多少？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=380, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLds0cj9RtZuibJXicmzqkfrVLvicKfIGVIpECSvhWlEwVdW8dUP8iaNFomtZrbQmbD1Nib2SOE1ck6GGg/132, createdBy=b03c1669891, createdName=zxyspine, createdTime=Fri Jan 19 08:48:00 CST 2018, time=2018-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548793, encodeId=af67548e93e3, content=是否接受中药提取物，中药单体这种？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=297, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/11/099c0105710974ef7b8f24c4ed199641.jpg, createdBy=f30e2045285, createdName=sesee, createdTime=Wed Nov 01 00:30:00 CST 2017, time=2017-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547595, encodeId=1e6b54e59586, content=你好.看样子蛮顺利的.<span class="quote">liudm0103 2016-06-16 发表::<br>研究方向:骨质疏松;基础研究; 审稿时间:约2个月 SCI(2014):3.973 2016-02-21 Submitted to journal 2016-02-22 With editor 2016-03-13 under review 2016-04-10 revise 2016-05-25 Revision Submitted to Journal 2016-05-26 With editor 2016-05-29 Completely accepted</span><span class="quote">liudm0103 2016-06-16 22:14:00 发表:<br>2016-02-21 Submitted to journal <br> 2016-02-22 With editor <br> 2016-03-13 under review <br> 2016-04-10 revise <br> 2016-05-25 Revision Submitted to Journal <br> 2016-05-26 With editor <br> 2016-05-29 Completely accepted</span>, beContent=liudm0103 2016-06-16 发表:: 研究方向:骨质疏松;基础研究; 审稿时间:约2个月 SCI(2014):3.973 2016-02-21 Submitted to journal 2016-02-22 With editor 2016-03-13 under review 2016-04-10 revise 2016-05-25 Revision Submitted to Journal 2016-05-26 With editor 2016-05-29 Completely accepted, objectType=tool_impact_factor, channel=null, level=null, likeNumber=377, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84812146588, createdName=txsyzu_32760595, createdTime=Mon Sep 25 00:00:00 CST 2017, time=2017-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=523818, encodeId=2c82523818ff, content=审稿速度:2.0<br>经验分享：2016-02-21 Submitted to journal <br> 2016-02-22 With editor <br> 2016-03-13 under review <br> 2016-04-10 revise <br> 2016-05-25 Revision Submitted to Journal <br> 2016-05-26 With editor <br> 2016-05-29 Completely accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=467, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=922218466, createdName=liudm0103, createdTime=Thu Jun 16 22:14:00 CST 2016, time=2016-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=511320, encodeId=2127511320f6, content=后续报道： <br> Bone是二区的杂志，审稿很严。。 <br> 去年11月底投出，审了两个多快三个月，2月份major revision and reconsider，三个reviewer的意见有30条左右。。仔细修改，反复讨论，改了满江红，三月初再投。 <br> 二审又审了一个月左右，两个reviewer接收，另一个reviewer同意接收但是对讨论和前言部分做了几处修改建议，所以然后小修，然后过了两三天，正式接收。 <br> 感觉：bone很严谨，每一处小细节都能问。不过针对意见好好回答，接收机会还是很大的。 <br> 各位同仁加油！ <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=571, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5cfa1614315, createdName=mileo, createdTime=Mon Apr 20 23:35:00 CST 2015, time=2015-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509631, encodeId=d1e750963180, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：Bone作为骨科领域老大（基础领域），而且审稿很古板，一直是超严格的。因此，发表真不容易，但若发表了，价值当然不低。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=506, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Sat Feb 07 10:34:00 CST 2015, time=2015-02-07, status=1, ipAttribution=)]
    2017-09-25 txsyzu_32760595

    你好.看样子蛮顺利的.liudm0103 2016-06-16 发表::
    研究方向:骨质疏松;基础研究; 审稿时间:约2个月 SCI(2014):3.973 2016-02-21 Submitted to journal 2016-02-22 With editor 2016-03-13 under review 2016-04-10 revise 2016-05-25 Revision Submitted to Journal 2016-05-26 With editor 2016-05-29 Completely accepted    liudm0103 2016-06-16 22:14:00 发表:
    2016-02-21 Submitted to journal
    2016-02-22 With editor
    2016-03-13 under review
    2016-04-10 revise
    2016-05-25 Revision Submitted to Journal
    2016-05-26 With editor
    2016-05-29 Completely accepted

    liudm0103 2016-06-16 发表:: 研究方向:骨质疏松;基础研究; 审稿时间:约2个月 SCI(2014):3.973 2016-02-21 Submitted to journal 2016-02-22 With editor 2016-03-13 under review 2016-04-10 revise 2016-05-25 Revision Submitted to Journal 2016-05-26 With editor 2016-05-29 Completely accepted

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=580463, encodeId=8cb6580463aa, content=这个杂志有版面费吗？<span class="quote">132****5832暂无昵称 2019-10-25 00:00:00 发表:<br>3个月</span>, beContent=132****5832暂无昵称 2019-10-25 00:00:00 发表: 3个月, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eo1Cbu9ibBiberkfx5dlu9cx1y63eGbtEEoTqskIOcnZ6lbYHErSGPR7r2R4hGmcqfjMlF7Bqo6ibxFQ/132, createdBy=34e51644539, createdName=diyizhaozhao, createdTime=Tue Nov 26 00:00:00 CST 2019, time=2019-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578691, encodeId=ffbf5e869116, content=3个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=213, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571993, encodeId=f5225e1993b8, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：有点坑，一审一个多月回来只说语言问题，润色回去后二审回来让转投bone reports, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/07/992397a31de8fe085a03a096beddda25.jpg, createdBy=9a581635059, createdName=Moke8966, createdTime=Sat Jun 08 00:00:00 CST 2019, time=2019-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849024, encodeId=d40784902403, content=内分泌学非常好的一个期刊，可以试着投一下，拒了也能收获不少意见 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dedd5414056, createdName=ms5251117139357251, createdTime=Wed Jan 02 14:27:24 CST 2019, time=2019-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551660, encodeId=7d7c551660d8, content=有没有大神算一下目前IF是多少？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=380, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLds0cj9RtZuibJXicmzqkfrVLvicKfIGVIpECSvhWlEwVdW8dUP8iaNFomtZrbQmbD1Nib2SOE1ck6GGg/132, createdBy=b03c1669891, createdName=zxyspine, createdTime=Fri Jan 19 08:48:00 CST 2018, time=2018-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548793, encodeId=af67548e93e3, content=是否接受中药提取物，中药单体这种？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=297, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/11/099c0105710974ef7b8f24c4ed199641.jpg, createdBy=f30e2045285, createdName=sesee, createdTime=Wed Nov 01 00:30:00 CST 2017, time=2017-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547595, encodeId=1e6b54e59586, content=你好.看样子蛮顺利的.<span class="quote">liudm0103 2016-06-16 发表::<br>研究方向:骨质疏松;基础研究; 审稿时间:约2个月 SCI(2014):3.973 2016-02-21 Submitted to journal 2016-02-22 With editor 2016-03-13 under review 2016-04-10 revise 2016-05-25 Revision Submitted to Journal 2016-05-26 With editor 2016-05-29 Completely accepted</span><span class="quote">liudm0103 2016-06-16 22:14:00 发表:<br>2016-02-21 Submitted to journal <br> 2016-02-22 With editor <br> 2016-03-13 under review <br> 2016-04-10 revise <br> 2016-05-25 Revision Submitted to Journal <br> 2016-05-26 With editor <br> 2016-05-29 Completely accepted</span>, beContent=liudm0103 2016-06-16 发表:: 研究方向:骨质疏松;基础研究; 审稿时间:约2个月 SCI(2014):3.973 2016-02-21 Submitted to journal 2016-02-22 With editor 2016-03-13 under review 2016-04-10 revise 2016-05-25 Revision Submitted to Journal 2016-05-26 With editor 2016-05-29 Completely accepted, objectType=tool_impact_factor, channel=null, level=null, likeNumber=377, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84812146588, createdName=txsyzu_32760595, createdTime=Mon Sep 25 00:00:00 CST 2017, time=2017-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=523818, encodeId=2c82523818ff, content=审稿速度:2.0<br>经验分享：2016-02-21 Submitted to journal <br> 2016-02-22 With editor <br> 2016-03-13 under review <br> 2016-04-10 revise <br> 2016-05-25 Revision Submitted to Journal <br> 2016-05-26 With editor <br> 2016-05-29 Completely accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=467, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=922218466, createdName=liudm0103, createdTime=Thu Jun 16 22:14:00 CST 2016, time=2016-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=511320, encodeId=2127511320f6, content=后续报道： <br> Bone是二区的杂志，审稿很严。。 <br> 去年11月底投出，审了两个多快三个月，2月份major revision and reconsider，三个reviewer的意见有30条左右。。仔细修改，反复讨论，改了满江红，三月初再投。 <br> 二审又审了一个月左右，两个reviewer接收，另一个reviewer同意接收但是对讨论和前言部分做了几处修改建议，所以然后小修，然后过了两三天，正式接收。 <br> 感觉：bone很严谨，每一处小细节都能问。不过针对意见好好回答，接收机会还是很大的。 <br> 各位同仁加油！ <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=571, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5cfa1614315, createdName=mileo, createdTime=Mon Apr 20 23:35:00 CST 2015, time=2015-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509631, encodeId=d1e750963180, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：Bone作为骨科领域老大（基础领域），而且审稿很古板，一直是超严格的。因此，发表真不容易，但若发表了，价值当然不低。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=506, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Sat Feb 07 10:34:00 CST 2015, time=2015-02-07, status=1, ipAttribution=)]
    2016-06-16 liudm0103

    审稿速度:2.0
    经验分享：2016-02-21 Submitted to journal
    2016-02-22 With editor
    2016-03-13 under review
    2016-04-10 revise
    2016-05-25 Revision Submitted to Journal
    2016-05-26 With editor
    2016-05-29 Completely accepted

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=580463, encodeId=8cb6580463aa, content=这个杂志有版面费吗？<span class="quote">132****5832暂无昵称 2019-10-25 00:00:00 发表:<br>3个月</span>, beContent=132****5832暂无昵称 2019-10-25 00:00:00 发表: 3个月, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eo1Cbu9ibBiberkfx5dlu9cx1y63eGbtEEoTqskIOcnZ6lbYHErSGPR7r2R4hGmcqfjMlF7Bqo6ibxFQ/132, createdBy=34e51644539, createdName=diyizhaozhao, createdTime=Tue Nov 26 00:00:00 CST 2019, time=2019-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578691, encodeId=ffbf5e869116, content=3个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=213, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571993, encodeId=f5225e1993b8, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：有点坑，一审一个多月回来只说语言问题，润色回去后二审回来让转投bone reports, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/07/992397a31de8fe085a03a096beddda25.jpg, createdBy=9a581635059, createdName=Moke8966, createdTime=Sat Jun 08 00:00:00 CST 2019, time=2019-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849024, encodeId=d40784902403, content=内分泌学非常好的一个期刊，可以试着投一下，拒了也能收获不少意见 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dedd5414056, createdName=ms5251117139357251, createdTime=Wed Jan 02 14:27:24 CST 2019, time=2019-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551660, encodeId=7d7c551660d8, content=有没有大神算一下目前IF是多少？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=380, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLds0cj9RtZuibJXicmzqkfrVLvicKfIGVIpECSvhWlEwVdW8dUP8iaNFomtZrbQmbD1Nib2SOE1ck6GGg/132, createdBy=b03c1669891, createdName=zxyspine, createdTime=Fri Jan 19 08:48:00 CST 2018, time=2018-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548793, encodeId=af67548e93e3, content=是否接受中药提取物，中药单体这种？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=297, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/11/099c0105710974ef7b8f24c4ed199641.jpg, createdBy=f30e2045285, createdName=sesee, createdTime=Wed Nov 01 00:30:00 CST 2017, time=2017-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547595, encodeId=1e6b54e59586, content=你好.看样子蛮顺利的.<span class="quote">liudm0103 2016-06-16 发表::<br>研究方向:骨质疏松;基础研究; 审稿时间:约2个月 SCI(2014):3.973 2016-02-21 Submitted to journal 2016-02-22 With editor 2016-03-13 under review 2016-04-10 revise 2016-05-25 Revision Submitted to Journal 2016-05-26 With editor 2016-05-29 Completely accepted</span><span class="quote">liudm0103 2016-06-16 22:14:00 发表:<br>2016-02-21 Submitted to journal <br> 2016-02-22 With editor <br> 2016-03-13 under review <br> 2016-04-10 revise <br> 2016-05-25 Revision Submitted to Journal <br> 2016-05-26 With editor <br> 2016-05-29 Completely accepted</span>, beContent=liudm0103 2016-06-16 发表:: 研究方向:骨质疏松;基础研究; 审稿时间:约2个月 SCI(2014):3.973 2016-02-21 Submitted to journal 2016-02-22 With editor 2016-03-13 under review 2016-04-10 revise 2016-05-25 Revision Submitted to Journal 2016-05-26 With editor 2016-05-29 Completely accepted, objectType=tool_impact_factor, channel=null, level=null, likeNumber=377, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84812146588, createdName=txsyzu_32760595, createdTime=Mon Sep 25 00:00:00 CST 2017, time=2017-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=523818, encodeId=2c82523818ff, content=审稿速度:2.0<br>经验分享：2016-02-21 Submitted to journal <br> 2016-02-22 With editor <br> 2016-03-13 under review <br> 2016-04-10 revise <br> 2016-05-25 Revision Submitted to Journal <br> 2016-05-26 With editor <br> 2016-05-29 Completely accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=467, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=922218466, createdName=liudm0103, createdTime=Thu Jun 16 22:14:00 CST 2016, time=2016-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=511320, encodeId=2127511320f6, content=后续报道： <br> Bone是二区的杂志，审稿很严。。 <br> 去年11月底投出，审了两个多快三个月，2月份major revision and reconsider，三个reviewer的意见有30条左右。。仔细修改，反复讨论，改了满江红，三月初再投。 <br> 二审又审了一个月左右，两个reviewer接收，另一个reviewer同意接收但是对讨论和前言部分做了几处修改建议，所以然后小修，然后过了两三天，正式接收。 <br> 感觉：bone很严谨，每一处小细节都能问。不过针对意见好好回答，接收机会还是很大的。 <br> 各位同仁加油！ <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=571, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5cfa1614315, createdName=mileo, createdTime=Mon Apr 20 23:35:00 CST 2015, time=2015-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509631, encodeId=d1e750963180, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：Bone作为骨科领域老大（基础领域），而且审稿很古板，一直是超严格的。因此，发表真不容易，但若发表了，价值当然不低。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=506, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Sat Feb 07 10:34:00 CST 2015, time=2015-02-07, status=1, ipAttribution=)]
    2015-04-20 mileo

    后续报道：
    Bone是二区的杂志，审稿很严。。
    去年11月底投出，审了两个多快三个月，2月份major revision and reconsider，三个reviewer的意见有30条左右。。仔细修改，反复讨论，改了满江红，三月初再投。
    二审又审了一个月左右，两个reviewer接收，另一个reviewer同意接收但是对讨论和前言部分做了几处修改建议，所以然后小修，然后过了两三天，正式接收。
    感觉：bone很严谨，每一处小细节都能问。不过针对意见好好回答，接收机会还是很大的。
    各位同仁加油！

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=580463, encodeId=8cb6580463aa, content=这个杂志有版面费吗？<span class="quote">132****5832暂无昵称 2019-10-25 00:00:00 发表:<br>3个月</span>, beContent=132****5832暂无昵称 2019-10-25 00:00:00 发表: 3个月, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eo1Cbu9ibBiberkfx5dlu9cx1y63eGbtEEoTqskIOcnZ6lbYHErSGPR7r2R4hGmcqfjMlF7Bqo6ibxFQ/132, createdBy=34e51644539, createdName=diyizhaozhao, createdTime=Tue Nov 26 00:00:00 CST 2019, time=2019-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578691, encodeId=ffbf5e869116, content=3个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=213, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571993, encodeId=f5225e1993b8, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：有点坑，一审一个多月回来只说语言问题，润色回去后二审回来让转投bone reports, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/07/992397a31de8fe085a03a096beddda25.jpg, createdBy=9a581635059, createdName=Moke8966, createdTime=Sat Jun 08 00:00:00 CST 2019, time=2019-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849024, encodeId=d40784902403, content=内分泌学非常好的一个期刊，可以试着投一下，拒了也能收获不少意见 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dedd5414056, createdName=ms5251117139357251, createdTime=Wed Jan 02 14:27:24 CST 2019, time=2019-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551660, encodeId=7d7c551660d8, content=有没有大神算一下目前IF是多少？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=380, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLds0cj9RtZuibJXicmzqkfrVLvicKfIGVIpECSvhWlEwVdW8dUP8iaNFomtZrbQmbD1Nib2SOE1ck6GGg/132, createdBy=b03c1669891, createdName=zxyspine, createdTime=Fri Jan 19 08:48:00 CST 2018, time=2018-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548793, encodeId=af67548e93e3, content=是否接受中药提取物，中药单体这种？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=297, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/11/099c0105710974ef7b8f24c4ed199641.jpg, createdBy=f30e2045285, createdName=sesee, createdTime=Wed Nov 01 00:30:00 CST 2017, time=2017-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547595, encodeId=1e6b54e59586, content=你好.看样子蛮顺利的.<span class="quote">liudm0103 2016-06-16 发表::<br>研究方向:骨质疏松;基础研究; 审稿时间:约2个月 SCI(2014):3.973 2016-02-21 Submitted to journal 2016-02-22 With editor 2016-03-13 under review 2016-04-10 revise 2016-05-25 Revision Submitted to Journal 2016-05-26 With editor 2016-05-29 Completely accepted</span><span class="quote">liudm0103 2016-06-16 22:14:00 发表:<br>2016-02-21 Submitted to journal <br> 2016-02-22 With editor <br> 2016-03-13 under review <br> 2016-04-10 revise <br> 2016-05-25 Revision Submitted to Journal <br> 2016-05-26 With editor <br> 2016-05-29 Completely accepted</span>, beContent=liudm0103 2016-06-16 发表:: 研究方向:骨质疏松;基础研究; 审稿时间:约2个月 SCI(2014):3.973 2016-02-21 Submitted to journal 2016-02-22 With editor 2016-03-13 under review 2016-04-10 revise 2016-05-25 Revision Submitted to Journal 2016-05-26 With editor 2016-05-29 Completely accepted, objectType=tool_impact_factor, channel=null, level=null, likeNumber=377, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84812146588, createdName=txsyzu_32760595, createdTime=Mon Sep 25 00:00:00 CST 2017, time=2017-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=523818, encodeId=2c82523818ff, content=审稿速度:2.0<br>经验分享：2016-02-21 Submitted to journal <br> 2016-02-22 With editor <br> 2016-03-13 under review <br> 2016-04-10 revise <br> 2016-05-25 Revision Submitted to Journal <br> 2016-05-26 With editor <br> 2016-05-29 Completely accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=467, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=922218466, createdName=liudm0103, createdTime=Thu Jun 16 22:14:00 CST 2016, time=2016-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=511320, encodeId=2127511320f6, content=后续报道： <br> Bone是二区的杂志，审稿很严。。 <br> 去年11月底投出，审了两个多快三个月，2月份major revision and reconsider，三个reviewer的意见有30条左右。。仔细修改，反复讨论，改了满江红，三月初再投。 <br> 二审又审了一个月左右，两个reviewer接收，另一个reviewer同意接收但是对讨论和前言部分做了几处修改建议，所以然后小修，然后过了两三天，正式接收。 <br> 感觉：bone很严谨，每一处小细节都能问。不过针对意见好好回答，接收机会还是很大的。 <br> 各位同仁加油！ <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=571, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5cfa1614315, createdName=mileo, createdTime=Mon Apr 20 23:35:00 CST 2015, time=2015-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509631, encodeId=d1e750963180, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：Bone作为骨科领域老大（基础领域），而且审稿很古板，一直是超严格的。因此，发表真不容易，但若发表了，价值当然不低。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=506, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Sat Feb 07 10:34:00 CST 2015, time=2015-02-07, status=1, ipAttribution=)]
    2015-02-07 medcardio

    审稿速度:2.0 | 投稿命中率:25.0
    经验分享：Bone作为骨科领域老大（基础领域），而且审稿很古板，一直是超严格的。因此，发表真不容易，但若发表了，价值当然不低。

    0

共42条页码: 2/5页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分